SVA [SINOVAC BIOTECH] 6-K: Sinovac Names Danny Chung Chief Financial Officer SVA

Ticker: SVA, Company: SINOVAC BIOTECH LTD, Type: 6-K, Date: 2012-05-22
Original SEC Filing: Click here


Webplus: SVA/20120522/6-K/2_EX-99.1/000.htm SEC Original: v313911_ex99-1.htm
Sinovac Names Danny Chung Chief Financial Officer SVA Beijing – May 14, 2012 – Sinovac Biotech Ltd. (Nasdaq: “Mr. Chung possesses the relevant experiences and credentials, which meet the Company’s needs,” said Dr. Weidong Yin, Chairman and CEO. “Beyond his audit and accounting expertise, Mr. Chung has proven adept in the financial management of Chinese divisions of multinational companies. We




Webplus: SVA/20120522/6-K/1/000.htm SEC Original: v313911_6k.htm



Company Information:

Ticker: SVA, Company: SINOVAC BIOTECH LTD, Type: 6-K, Date: 2012-05-22CIK: 0001084201, Location: F4, SIC: 2834, SIC Desc: PHARMACEUTICAL PREPARATIONS
Business Phone & Address:
39 SHANGDI XI ROAD
BEIJING 100085

Home Page Forums

By | 2016-03-24T01:07:23+00:00 May 22nd, 2012|Categories: Chinese Stocks, SVA, Webplus ver|Tags: , , , , , |0 Comments

About the Author:

Leave A Comment

Skip to toolbar